Clinical trial · people

VIP fragment VIP10-28 boosted, not blocked, skin vessel widening

Checked against the paper Clinical trialPublished by PepVault

The takeaway

This is a lab-method paper: it shows that in human skin the VIP fragment VIP10-28 strengthened vessel widening rather than blocking it, and it says little about VIP's effects as something people take.

Kind
Clinical trial
Studied in
People
Published
2005
Journal
J Appl Physiol (1985)

What they tested

The team tested whether VIP10-28, a piece of VIP, could block VIP-driven widening of skin blood vessels, so they could learn how much VIP drives the skin's widening of vessels during heat stress.

How the study was done

A clinical study in people run as 4 experiments with 12, 6, 6 and 6 participants. Treated skin sites were compared with control sites, some also given a nitric oxide synthase (NOS) blocker or an H1 histamine blocker. Skin blood flow was measured by laser Doppler and scaled to the maximum widening produced by 28 mM sodium nitroprusside.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking VIP? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In people, VIP10-28 increased the widening of skin blood vessels in response to added VIP and in response to whole body heating, compared with control sites (P < 0.05). Blocking NOS did not change this increased widening during VIP or heating (P > 0.05), and H1 blockers did not change it during heating (P > 0.05). In the fourth experiment, when skin blood flow was already raised before heating, the rise during heating was smaller as a percentage of the maximum. The team concluded that VIP10-28 may be a poor tool for blocking VIP in human skin.

What it doesn’t show

Each experiment had only 6 to 12 people, and it looked only at skin blood flow. It tested VIP10-28 as a research blocker, not VIP or the fragment as a treatment.

The paper

Wilkins et al. Vasoactive intestinal peptide fragment VIP10-28 and active vasodilation in human skin. J Appl Physiol (1985). 2005.

The compound

More studies on VIP

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking VIP? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo